Visudyne 15Mg Inj

Visudyne 15Mg Inj belongs to the group of medicines called photosensitizing agents used in combination with photodynamic therapy to treat the wet form of age-related macular degeneration, pathological myopia, or ocular histoplasmosis.

Visudyne 15Mg Inj contains Verteporfin, which is distributed within the body through the blood vessels, including the blood vessels at the back of the eye. It is activated by light and closes the leaking blood vessels.

Visudyne 15Mg Inj may cause certain side effects, such as infusion site reactions, nausea, and tiredness. Most of these side effects may not require medical attention and resolve over time. However, you are advised to talk to the doctor if any of the side effects persist or worsen. Visudyne 15Mg Inj will be administered by a healthcare professional. Do not self-administer.

Avoid receiving the medicine if you are allergic to any of the components present in it. Keep the doctor informed about your health condition and medications to rule out any side effects/interactions. Consult the doctor if you are pregnant or planning for pregnancy. It is advised to avoid breastfeeding for 48 hours after administration of Visudyne 15Mg Inj.

Visudyne 15Mg Inj is used in the treatment of Wet form of age-related macular degeneration, pathological myopia, or ocular histoplasmosis. The detailed uses of Visudyne 15Mg Inj are as follows:

• Treatment of Wet Age-Related Macular Degeneration (AMD): Visudyne 15Mg Inj is used in combination with photodynamic therapy (PDT) to treat abnormal, leaky blood vessels in the retina that cause vision loss in wet AMD.
• Management of Pathologic Myopia and Ocular Histoplasmosis: Visudyne 15Mg Inj helps close abnormal blood vessels in the eye caused by severe nearsightedness or fungal infections, preventing further retinal damage.
• Photodynamic Activation Mechanism: After intravenous injection, Visudyne 15Mg Inj is activated by a non-thermal laser light, producing reactive oxygen species that damage and seal off abnormal vessels without harming surrounding tissue.
• Vision Preservation: By targeting and closing these vessels, Visudyne 15Mg Inj helps slow the progression of vision loss, especially central vision, which is crucial for reading and recognizing faces.

• Visudyne 15Mg Inj will be administered by a healthcare professional.
• Do not self-administer it.

Visudyne 15Mg Inj belongs to the group of medicines called photosensitizing agents used in combination with photodynamic therapy (treatment with laser light) to treat the wet form of age-related macular degeneration, pathological myopia, or ocular histoplasmosis. Visudyne 15Mg Inj contains Verteporfin, which is distributed within the body through the blood vessels, including the blood vessels at the back of the eye. It is activated by light and closes up leaking blood vessels.

Do not receive Visudyne 15Mg Inj if you are allergic to any of its components, if you have porphyria (a rare condition that may increase sensitivity to light), severe liver problems, or if you are breastfeeding. Consult the doctor if you are pregnant or planning for pregnancy. Inform the doctor if you are being treated with radiation therapy or if you have gallbladder problems, blockage of the bile duct, or liver problems. Let the doctor know if you are taking any other medicines, including supplements or herbal products. This medicine is not recommended for children as the safety is not established.